Stock Taper
EVO
EVOTEC SE
NASDAQ
$1.91
▼ DOWN 3.05% (-0.06)

KEY STATISTICS

Market Cap$678.51 M
52w High$4.27
52w Low$1.87
Dividend Yield4.93%
FrequencyMonthly
P/E-2.70
Volume28.20K
Shares Out.355.24M

COMPANY

LEADERSHIP

Christian Wojczewski
CHIEF EXECUTIVE
Christian Wojczewski

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 5, 2004
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
4,553

PRICE TARGET

Target High$4.00
Target Low$2.00
Target Median$3.00
Target Consensus$3.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$157.13M
NOV
5
THU

SPLIT RECORD

DATETYPERATIO
2021-10-20Forward4:1
2008-05-05Forward10000:5271

PRICE

$1.91 ▼ DOWN 3.05% (−$0.06)
OVERLAYS
$1.91$1.92$1.93$1.959:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM1.91

About Evotec SE

https://www.evotec.com ↗

Evotec SE is a Hamburg-based global drug discovery and development partner collaborating with major pharma companies across diverse therapeutic areas.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A SERVICE EVOTEC SE IS KNOWN FOR

Just - Evotec Biologics

A CDMO specializing in biologics, leveraging AI, machine learning, and continuous manufacturing to accelerate and reduce the cost of developing complex biological medicines for pharma and biotech partners.

COMPETITORS

Revenue by Products

IconPRODUCTFY2025
Other Fees$300K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score1

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
SYRE$90.36COMPARE
PHVS$35.32COMPARE
NVCR$17.82COMPARE
ALVO$4.95COMPARE
AZTA$32.95COMPARE
SDGR$19.70COMPARE
HROW$37.27COMPARE
TDOC$6.50COMPARE